The prospects of glycan biomarkers for the diagnosis of diseases
- PMID: 19081926
- DOI: 10.1039/b811781k
The prospects of glycan biomarkers for the diagnosis of diseases
Abstract
Over 40 years of literature shows that glycosylation is greatly affected by diseases such as cancer. This opinion article argues the intrinsic advantages of using glycans as disease markers over other biomolecules and the potential of glycan profiling for diagnosing and determining the progression of disease.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
